{"transactions":[{"id":718488,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:05:19.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1781,"price":11.93,"value":21247.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":110263,"source":{"system":"sec-edgar","filing":"0001193125-26-294477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526294477/ownership.xml","form_type":"4"}},{"id":841917,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-16T18:48:58.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":30995,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":30995,"derivative":{"underlying":"Common Stock","underlying_shares":30995},"source":{"system":"sec-edgar","filing":"0001193125-26-108077","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526108077/ownership.xml","form_type":"4"}},{"id":841916,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-16T18:48:58.000Z","date":"2026-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":15151,"price":11.53,"value":174691.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":108482,"source":{"system":"sec-edgar","filing":"0001193125-26-108077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526108077/ownership.xml","form_type":"4"}},{"id":841915,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-16T18:48:58.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":30995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":123633,"source":{"system":"sec-edgar","filing":"0001193125-26-108077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526108077/ownership.xml","form_type":"4"}},{"id":844132,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-13T19:08:11.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":false,"shares":8291,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8291},"source":{"system":"sec-edgar","filing":"0001193125-26-105953","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526105953/ownership.xml","form_type":"4"}},{"id":844131,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-13T19:08:11.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3224,"price":11.62,"value":37462.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":92638,"source":{"system":"sec-edgar","filing":"0001193125-26-105953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526105953/ownership.xml","form_type":"4"}},{"id":844130,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-13T19:08:11.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":true,"shares":8291,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":95862,"source":{"system":"sec-edgar","filing":"0001193125-26-105953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526105953/ownership.xml","form_type":"4"}},{"id":851329,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T21:00:28.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":17778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17778},"source":{"system":"sec-edgar","filing":"0001193125-26-100353","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526100353/ownership.xml","form_type":"4"}},{"id":851328,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:00:28.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":6913,"price":10,"value":69130.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":87571,"source":{"system":"sec-edgar","filing":"0001193125-26-100353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526100353/ownership.xml","form_type":"4"}},{"id":851327,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:00:28.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":17778,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":94484,"source":{"system":"sec-edgar","filing":"0001193125-26-100353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526100353/ownership.xml","form_type":"4"}},{"id":858875,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:43:30.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":8856,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":35424,"derivative":{"underlying":"Common Stock","underlying_shares":8856},"source":{"system":"sec-edgar","filing":"0001193125-26-094131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526094131/ownership.xml","form_type":"4"}},{"id":858874,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:43:30.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4506,"price":8.84,"value":39833.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":76706,"source":{"system":"sec-edgar","filing":"0001193125-26-094131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526094131/ownership.xml","form_type":"4"}},{"id":858873,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:43:30.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":8856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":81212,"source":{"system":"sec-edgar","filing":"0001193125-26-094131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526094131/ownership.xml","form_type":"4"}},{"id":893659,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T21:11:31.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":51546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029."}],"balance_after":51546,"derivative":{"underlying":"Common Stock","underlying_shares":51546},"source":{"system":"sec-edgar","filing":"0001193125-26-059382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526059382/ownership.xml","form_type":"4"}},{"id":952089,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:57:18.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":1,"price":9.57,"value":9.57,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":72356,"source":{"system":"sec-edgar","filing":"0001193125-26-002980","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000119312526002980/ownership.xml","form_type":"4"}},{"id":1095668,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-07-02T21:11:30.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":1608,"price":10.15,"value":16321.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":72355,"source":{"system":"sec-edgar","filing":"0000950170-25-093183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025093183/ownership.xml","form_type":"4"}},{"id":1113754,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-06-12T23:14:45.000Z","date":"2025-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3561,"price":13.29,"value":47325.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":70747,"source":{"system":"sec-edgar","filing":"0000950170-25-085702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025085702/ownership.xml","form_type":"4"}},{"id":1205916,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-14T20:40:14.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":false,"shares":15497,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":61990,"derivative":{"underlying":"Common Stock","underlying_shares":15497},"source":{"system":"sec-edgar","filing":"0000950170-25-039514","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025039514/ownership.xml","form_type":"4"}},{"id":1205915,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-14T20:40:14.000Z","date":"2025-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":5545,"price":13.18,"value":73083.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":74308,"source":{"system":"sec-edgar","filing":"0000950170-25-039514","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025039514/ownership.xml","form_type":"4"}},{"id":1205914,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-14T20:40:14.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":true,"shares":15497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":79853,"source":{"system":"sec-edgar","filing":"0000950170-25-039514","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025039514/ownership.xml","form_type":"4"}},{"id":1208023,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-13T22:19:37.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":8292,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":8291,"derivative":{"underlying":"Common Stock","underlying_shares":8292},"source":{"system":"sec-edgar","filing":"0000950170-25-038956","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025038956/ownership.xml","form_type":"4"}},{"id":1208022,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-13T22:19:37.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2967,"price":12.7,"value":37680.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":64356,"source":{"system":"sec-edgar","filing":"0000950170-25-038956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025038956/ownership.xml","form_type":"4"}},{"id":1208021,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-13T22:19:37.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":8292,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":67323,"source":{"system":"sec-edgar","filing":"0000950170-25-038956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025038956/ownership.xml","form_type":"4"}},{"id":1215381,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T23:52:11.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":false,"shares":17777,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":17778,"derivative":{"underlying":"Common Stock","underlying_shares":17777},"source":{"system":"sec-edgar","filing":"0000950170-25-036675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025036675/ownership.xml","form_type":"4"}},{"id":1215380,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-10T23:52:11.000Z","date":"2025-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":6361,"price":13.19,"value":83901.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":59031,"source":{"system":"sec-edgar","filing":"0000950170-25-036675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025036675/ownership.xml","form_type":"4"}},{"id":1215379,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-10T23:52:11.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":true,"shares":17777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":65392,"source":{"system":"sec-edgar","filing":"0000950170-25-036675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025036675/ownership.xml","form_type":"4"}},{"id":1229658,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T22:06:12.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":44280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028."}],"balance_after":44280,"derivative":{"underlying":"Common Stock","underlying_shares":44280},"source":{"system":"sec-edgar","filing":"0000950170-25-032395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025032395/ownership.xml","form_type":"4"}},{"id":1246772,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-25T21:59:13.000Z","date":"2025-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":908,"price":16.72,"value":15181.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":47615,"source":{"system":"sec-edgar","filing":"0000950170-25-026802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025026802/ownership.xml","form_type":"4"}},{"id":1315409,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:15:53.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":251,"price":4.53,"value":1137.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2024 through December 31, 2024. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":48523,"source":{"system":"sec-edgar","filing":"0000950170-25-001349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000095017025001349/ownership.xml","form_type":"4"}},{"id":1426667,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-08-21T20:18:57.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":420,"price":11.26,"value":4729.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":48272,"source":{"system":"sec-edgar","filing":"0001285550-24-000104","document":"wk-form4_1724271531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000104/wk-form4_1724271531.xml","form_type":"4"}},{"id":1463476,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-07-02T21:26:05.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":4.58,"value":16030.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2024 through June 30, 2024. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":48692,"source":{"system":"sec-edgar","filing":"0001285550-24-000090","document":"wk-form4_1719955559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000090/wk-form4_1719955559.xml","form_type":"4"}},{"id":1483761,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-11T23:32:54.000Z","date":"2024-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2502,"price":5.74,"value":14361.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":45192,"source":{"system":"sec-edgar","filing":"0001285550-24-000082","document":"wk-form4_1718148767.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000082/wk-form4_1718148767.xml","form_type":"4"}},{"id":1505760,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T20:39:59.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":77487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 12, 2025; (ii) 40% of the total shares on March 12, 2026; and (iii) 40% of the total shares on March 12, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 12, 2025; (ii) 40% of the total shares on March 12, 2026; and (iii) 40% of the total shares on March 12, 2027."}],"balance_after":77487,"derivative":{"underlying":"Common Stock","underlying_shares":77487},"source":{"system":"sec-edgar","filing":"0001285550-24-000075","document":"wk-form4_1716410373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000075/wk-form4_1716410373.xml","form_type":"4"}},{"id":1579059,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-13T20:52:14.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":16583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 50% of the total shares on the first anniversary of the grant date and (ii) 50% of the total shares on the second anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 50% of the total shares on the first anniversary of the grant date and (ii) 50% of the total shares on the second anniversary of the grant date."}],"balance_after":16583,"derivative":{"underlying":"Common Stock","underlying_shares":16583},"source":{"system":"sec-edgar","filing":"0001285550-24-000035","document":"wk-form4_1710363125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000035/wk-form4_1710363125.xml","form_type":"4"}},{"id":1587178,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-08T21:40:47.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":8889,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":35555,"derivative":{"underlying":"Common Stock","underlying_shares":8889},"source":{"system":"sec-edgar","filing":"0001285550-24-000025","document":"wk-form4_1709934037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000025/wk-form4_1709934037.xml","form_type":"4"}},{"id":1587177,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-03-08T21:40:47.000Z","date":"2024-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":3180,"price":6.24,"value":19843.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":47694,"source":{"system":"sec-edgar","filing":"0001285550-24-000025","document":"wk-form4_1709934037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000025/wk-form4_1709934037.xml","form_type":"4"}},{"id":1587176,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-03-08T21:40:47.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":8889,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50874,"source":{"system":"sec-edgar","filing":"0001285550-24-000025","document":"wk-form4_1709934037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000025/wk-form4_1709934037.xml","form_type":"4"}},{"id":1622899,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2024-02-23T23:12:10.000Z","date":"2024-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1039,"price":7.49,"value":7782.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":41985,"source":{"system":"sec-edgar","filing":"0001285550-24-000018","document":"wk-form4_1708729921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000018/wk-form4_1708729921.xml","form_type":"4"}},{"id":1693363,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2024-01-04T01:52:37.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":378,"price":5.77,"value":2181.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first business day or last business day of the purchase period."}],"balance_after":43024,"source":{"system":"sec-edgar","filing":"0001285550-24-000014","document":"wk-form4_1704333148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555024000014/wk-form4_1704333148.xml","form_type":"4"}},{"id":1833081,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2023-07-07T16:28:59.000Z","date":"2023-07-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1730,"price":6.53,"value":11296.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":42646,"source":{"system":"sec-edgar","filing":"0001285550-23-000086","document":"wf-form4_168874732835644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000086/wf-form4_168874732835644.xml","form_type":"4"}},{"id":1836883,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2023-07-05T21:47:39.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2682,"price":6.15,"value":16494.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2023 through June 30, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":44376,"source":{"system":"sec-edgar","filing":"0001285550-23-000083","document":"wf-form4_168859365052991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000083/wf-form4_168859365052991.xml","form_type":"4"}},{"id":1857475,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2023-06-13T21:02:26.000Z","date":"2023-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1212,"price":6.91,"value":8374.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":41694,"source":{"system":"sec-edgar","filing":"0001285550-23-000069","document":"wf-form4_168669013184744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000069/wf-form4_168669013184744.xml","form_type":"4"}},{"id":1963683,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Restricted Stock Units","published_at":"2023-03-08T21:51:36.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":44444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":44444,"derivative":{"underlying":"Common Stock","underlying_shares":44444},"source":{"system":"sec-edgar","filing":"0001285550-23-000029","document":"wf-form4_167831228291190.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000029/wf-form4_167831228291190.xml","form_type":"4"}},{"id":1963682,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T21:51:36.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":14814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":14814,"derivative":{"exercise_price":8.1,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":14814},"source":{"system":"sec-edgar","filing":"0001285550-23-000029","document":"wf-form4_167831228291190.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000029/wf-form4_167831228291190.xml","form_type":"4"}},{"id":1996326,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2023-02-23T21:39:43.000Z","date":"2023-02-22","kind":"tax_withholding","acquired":false,"shares":514,"price":8.55,"value":4394.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":42906,"source":{"system":"sec-edgar","filing":"0001285550-23-000016","document":"wf-form4_167718836083205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000016/wf-form4_167718836083205.xml","form_type":"4"}},{"id":2042396,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2023-01-30T19:04:40.000Z","date":"2022-12-30","kind":"other","acquired":true,"shares":728,"price":7.2,"value":5241.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":43420,"source":{"system":"sec-edgar","filing":"0001285550-23-000014","document":"wf-form5_167510546534801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555023000014/wf-form5_167510546534801.xml","form_type":"5"}},{"id":2176287,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2022-08-23T22:13:01.000Z","date":"2022-08-20","kind":"tax_withholding","acquired":false,"shares":203,"price":13.24,"value":2687.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,369 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan."}],"balance_after":42692,"source":{"system":"sec-edgar","filing":"0001285550-22-000050","document":"wf-form4_166129276607234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555022000050/wf-form4_166129276607234.xml","form_type":"4"}},{"id":2210073,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2022-07-08T22:41:40.000Z","date":"2022-07-06","kind":"tax_withholding","acquired":false,"shares":1685,"price":13.87,"value":23370.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":41526,"source":{"system":"sec-edgar","filing":"0001285550-22-000034","document":"wf-form4_165732008175132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555022000034/wf-form4_165732008175132.xml","form_type":"4"}},{"id":2232918,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T20:15:55.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":11685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":11685,"derivative":{"exercise_price":11.41,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":11685},"source":{"system":"sec-edgar","filing":"0001285550-22-000024","document":"wf-form4_165523772954876.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555022000024/wf-form4_165523772954876.xml","form_type":"4"}},{"id":2232917,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32994,"kind":"person","name":"STIGALL L. JEREMY","position":1,"cik":"0001929859","reported_name":"STIGALL L. JEREMY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM, Biologics & Drug Delivery"}}],"security":"Common Stock","published_at":"2022-06-14T20:15:55.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":17528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":43211,"source":{"system":"sec-edgar","filing":"0001285550-22-000024","document":"wf-form4_165523772954876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1929859/000128555022000024/wf-form4_165523772954876.xml","form_type":"4"}}]}